Does high testosterone actually cause hair loss? The DHT question

What's this video probably claiming?

Based on the caption and hashtag framing, @popstarlabs is likely walking viewers through the popular "but my testosterone is normal" confusion around androgenetic alopecia. The hook, hair thinning but T levels are high, suggests the video is pushing back on the oversimplified idea that testosterone itself is the direct culprit. That's a reasonable starting point. The creator is probably arguing that dihydrotestosterone (DHT), not total testosterone, is the actual driver, and that some men with completely normal testosterone levels still lose hair because of how sensitive their follicles are at the receptor level. TRT-adjacent content on TikTok frequently uses this framing to reassure men considering hormone therapy that their labs don't tell the whole story. The #knowyourbody and #popstarscience tags suggest a pop-science explainer tone, which can be useful when accurate but tends to flatten nuance around genetic susceptibility and the non-linear relationship between androgens and follicle miniaturization.

What does the science actually show?

The core biology here is well-established. Type II 5-alpha reductase converts testosterone into DHT in the scalp, and DHT binds to androgen receptors in genetically susceptible hair follicles, triggering progressive miniaturization. Imperato-McGinley et al. (1974, Journal of Clinical Investigation) showed that men with 5-alpha reductase deficiency retain scalp hair into adulthood, which gave researchers the first strong causal evidence for DHT's role. But total serum testosterone is a genuinely poor predictor of hair loss risk. Kaufman (2002, Journal of the American Academy of Dermatology) reviewed the clinical literature and found no consistent correlation between circulating testosterone concentrations and androgenetic alopecia severity. What matters more is follicular androgen receptor sensitivity, which is largely genetic. The AR gene on the X chromosome is the primary heritability factor. Finasteride clinical trials (Kaufman et al., 1998, Journal of the American Academy of Dermatology) showed that reducing DHT by approximately 60-70% via 1 mg daily dosing slowed or reversed hair loss in roughly 83% of men over two years, reinforcing DHT's mechanistic role without implicating total T.

Where does the social media noise diverge from clinical reality?

Here's where TRT-adjacent content tends to get slippery. The accurate claim that total testosterone doesn't correlate with hair loss risk gets quietly extended into an implication that TRT is therefore safe for hair. That's not what the data supports. Exogenous testosterone administration, regardless of baseline levels, increases substrate availability for 5-alpha reductase. Studies on testosterone cypionate and enanthate consistently show elevated DHT in users, sometimes 2-3 times above baseline depending on dose and individual 5-alpha reductase activity. Rahnema et al. (2014, Fertility and Sterility) documented accelerated androgenetic alopecia as a recognized adverse effect of anabolic androgen use. The mechanism isn't mysterious. More testosterone in circulation means more conversion opportunity. Men with a genetic predisposition who start TRT sometimes notice rapid progression within months. The social media version of this science tends to reassure rather than contextualize that risk, which is a problem when the platform is adjacent to a telehealth service offering TRT prescriptions.

What should you actually know?

A few things the caption framing probably won't emphasize enough. First, scalp DHT levels and serum DHT levels are not the same thing, and most standard labs measure serum. Second, the relationship between androgen sensitivity and hair follicle behavior is tissue-specific, which is why DHT causes beard growth while simultaneously causing scalp follicle miniaturization in susceptible individuals. Third, treatments that reduce DHT systemically, finasteride and dutasteride, come with documented sexual side effects that require honest informed consent discussions, not just reassurance. Fourth, men on TRT who are concerned about hair loss have clinical options, including topical finasteride formulations that reduce scalp DHT with less systemic exposure, but the evidence base for those formulations is thinner than for oral finasteride. Caserini et al. (2016, Drug Delivery) showed meaningful scalp DHT reduction with topical delivery, though long-term comparative data against oral formulations is still limited. Know your genetics. Know your actual DHT levels. And get clinical guidance before starting or modifying any hormone therapy based on TikTok framing.